Related Experiment Video
Updated: Oct 19, 2025
Development of New Therapeutic Applications Using Microfluidics
Published on: October 1, 2007
Microfluidics in cardiovascular disease research: state of the art and future outlook
Qingming Ma1, Haixia Ma2, Fenglan Xu3
1School of Pharmacy, Qingdao University, Qingdao, 266071 China.
Insights
Microfluidics offers a powerful approach to understanding cardiovascular diseases. This technology aids in studying disease mechanisms, developing diagnostics, and creating new treatments for better cardiovascular health.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Microfluidics Technology
Background:
- Cardiovascular diseases (CVDs) represent a major global health burden, necessitating advanced research methods.
- Current research efforts focus on replicating the cardiovascular system to understand CVD pathogenesis, diagnosis, and treatment.
- Microfluidics presents a versatile platform for a comprehensive approach to CVD research.
Purpose of the Study:
- To review the application of microfluidics in comprehensive cardiovascular disease research.
- To discuss the integral role of microfluidics in studying CVD pathogenetic mechanisms, diagnostics, and therapeutics.
- To highlight challenges and future directions for microfluidics in CVD research.
Main Methods:
- Review of microfluidic-based organ-on-a-chip systems for investigating CVD pathogenetic mechanisms.
- Summary of microfluidic-based diagnostic methods for cardiovascular diseases.
- Review of microfluidic applications in drug evaluation, screening, and novel delivery vehicles for CVD.
Main Results:
- Microfluidics enables detailed investigation of critical pathogenetic mechanisms in typical cardiovascular diseases.
- Microfluidic platforms facilitate the development of accurate diagnostic tools for cardiovascular conditions.
- Microfluidics aids in cardiovascular drug evaluation, screening, and the creation of innovative drug delivery systems.
Conclusions:
- Microfluidics is a key technology for a holistic understanding and integrated research of cardiovascular diseases.
- This technology supports advancements in understanding CVD pathogenesis, improving diagnostics, and developing novel therapeutics.
- Further development of microfluidics holds significant promise for future cardiovascular disease research and clinical applications.
Abstract:
Due to extremely severe morbidity and mortality worldwide, it is worth achieving a more in-depth and comprehensive understanding of cardiovascular diseases. Tremendous effort has been made to replicate the cardiovascular system and investigate the pathogenesis, diagnosis and treatment of cardiovascular diseases. Microfluidics can be used as a versatile primary strategy to achieve a holistic picture of cardiovascular disease. Here, a brief review of the application of microfluidics in comprehensive cardiovascular disease research is presented, with specific discussions of the characteristics of microfluidics for investigating cardiovascular diseases integrally, including the study of pathogenetic mechanisms, the development of accurate diagnostic methods and the establishment of therapeutic treatments. Investigations of critical pathogenetic mechanisms for typical cardiovascular diseases by microfluidic-based organ-on-a-chip are categorized and reviewed, followed by a detailed summary of microfluidic-based accurate diagnostic methods. Microfluidic-assisted cardiovascular drug evaluation and screening as well as the fabrication of novel delivery vehicles are also reviewed. Finally, the challenges with and outlook on further advancing the use of microfluidics technology in cardiovascular disease research are highlighted and discussed.
